ClinConnect ClinConnect Logo
Search / Trial NCT07063589

Cannabis Use Patterns Among Young Adults and Associations With Social and Health Outcomes.

Launched by CENTRE HOSPITALIER DE L'UNIVERSITÉ DE MONTRÉAL (CHUM) · Jul 2, 2025

Trial Information

Current as of July 25, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how young adults aged 18 to 24 use cannabis (marijuana) in their everyday lives. Researchers want to learn about different patterns of cannabis use—like how often people use it, the types of products they choose, and the amounts of active ingredients they consume—over a two-year period. The goal is to better understand how these use patterns might relate to social and health outcomes for regular or daily users.

To take part, you need to be between 18 and 24 years old, have used cannabis at least once a week in the past three months, be able to read and speak English or French, have access to a mobile phone, and be willing to follow the study’s instructions. People who are currently in treatment for cannabis problems, using cannabis for medical reasons, or involved in other cannabis-related studies cannot join. Participants will be asked to share information about their cannabis use over time, helping researchers track changes and gather useful insights. This study is not yet recruiting, but it aims to better understand young adults’ cannabis habits to support healthier choices in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 18 to 24 years of age;
  • Cannabis use frequency of at least 1 day/week in the past three months;
  • Ability to speak and read French or English;
  • willingness to comply with all study procedures;
  • access to a mobile phone.
  • Exclusion Criteria:
  • Planned extended absence during study period (e.g. pending legal action, surgery, incarceration, inpatient residential program) which, in the opinion of the research staff, might prevent completion of the study;
  • Current or anticipated treatment for cannabis use disorder, confirmed via self-report;
  • Medical document authorizing the use of cannabis for medical purposes;
  • Participation in clinical studies or undergoing other investigational procedures involving cannabis or cannabinoids administration.

About Centre Hospitalier De L'université De Montréal (Chum)

The Centre Hospitalier de l'Université de Montréal (CHUM) is a leading academic health institution in Canada, dedicated to advancing patient care through innovative research and clinical excellence. As a prominent sponsor of clinical trials, CHUM is committed to leveraging its multidisciplinary expertise and state-of-the-art facilities to facilitate groundbreaking studies that enhance medical knowledge and improve health outcomes. Collaborating with a network of healthcare professionals and researchers, CHUM fosters a rigorous research environment that prioritizes patient safety, ethical standards, and scientific integrity, positioning itself at the forefront of medical advancements.

Locations

Montréal, Quebec, Canada

Patients applied

0 patients applied

Trial Officials

Didier Jutras-Aswad, MD, MS

Principal Investigator

CRCHUM

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported